Early 200 MW delivery to CoreWeave: Can Core Scientific stock extend gains?

Early 200 MW delivery to CoreWeave: Can Core Scientific stock extend gains?
Core Scientific jumps 7.69% to $21.28

Core Scientific (CORZ) stock is trading at $21.28, posting a 7.69% gain on the day. The price sits above its key short-term moving average while remaining under pressure from medium-term averages and holding strong above longer-term support levels.

CORZ price prediction
24H 3.15%
$12.13
48H 2.89%
$12.1
7D 3.23%
$12.14
1M -24.23%
$8.91
3M -47.02%
$6.23
6M -49.32%
$5.96
12M -45.75%
$6.38
Current price: $11.76 0.3200 2.80%
Closed 11/06
Daily range 11.20 Arrow from to Icon 12.42
Weekly range 10.61 Arrow from to Icon 14.23
Loading...

Highlights

  • Core Scientific delivered 200 megawatts to CoreWeave ahead of schedule, expanding infrastructure for cloud and AI workloads.
  • The early buildout increases near-term service capacity and is generating institutional interest in Core Scientific stock.
  • Shares of Core Scientific rallied 7.69% to $21.28 with overbought technical signals and a projected trading range of $19.24 to $22.30.

Early infrastructure delivery fuels institutional demand resurgence

Core Scientific delivered an additional 200 megawatts to CoreWeave ahead of schedule, according to Benzinga. This early buildout expands its available infrastructure for large-scale cloud and AI workloads, directly enhancing its near-term service capacity and positioning CORZ as a key partner for enterprise customers. The accelerated deployment highlights robust demand on the client side and is driving renewed institutional interest in the company’s operational trajectory.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Overbought momentum and bearish MACD signal reversal risk

On the technical side, CORZ trades above the MA-20 and below the MA-50 on the h1 chart, while remaining firmly above the MA-200 on the daily timeframe. The Ichimoku Kijun at $20.54 serves as immediate support. On the h1 chart, technical indicators are mixed: MACD signals strong sell momentum even as RSI reads 62.02, pointing to buyer strength. Stoch RSI, CCI, and Bull/Bear Power all reflect pronounced overbought conditions, while ADX and the Awesome Oscillator appear neutral. This divergence between overbought oscillators and a bearish MACD may be an early warning of a potential short-term reversal.

Retracement risk prevails as range-bound outlook sets in

Looking ahead, the near-term trading range is projected between $19.24 and $22.30. There is a 48% probability for further upside and a 52% chance of a move lower, tipping the balance modestly toward a short-term retracement in typical volatility. The baseline scenario envisions price consolidating within this band, with a bullish outcome dependent on a breakout above resistance, while a bearish scenario would see a break below immediate support at $20.54, opening a test of the lower range.

Viktoras Karapetjanc, expert at Traders Union, sees Core Scientific’s early infrastructure expansion as a key advantage in building client trust and institutional demand. He believes strong macro and sentiment factors support a constructive outlook, despite mixed technicals and possible short-term volatility. The expanded capacity for AI and cloud clients signals robust fundamentals. In his view, long-term investors should watch for consolidation near $20.54 support. "If CORZ maintains momentum above immediate supports, the technical and fundamental tailwinds could unlock fresh upside for proactive holders," says Karapetjanc.

Previously it was reported that Core Scientific faced ongoing technical challenges and displayed a bearish-to-neutral outlook amid persistent industry headwinds. The current analysis adds a near-term dimension, highlighting a technical setup where a break below $20.54 could signal downside risk toward the lower end of the projected trading range.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.